Glutathione Peroxidase.

Glutathione peroxidase is a selenoenzyme with selenocysteine in its active site, so its activity tracks selenium status directly. Without adequate selenium the apoenzyme cannot be completed.

Selenomethionine enters the general methionine pool and releases selenium for selenocysteine synthesis, which the enzyme requires at its active site. It is the common food form of the mineral this enzyme depends on.

Selenocysteine is the exact residue inserted at the catalytic site of glutathione peroxidase during translation. Supplying selenium in this form feeds the pathway that builds the enzyme.

The enzyme reduces hydrogen peroxide and lipid hydroperoxides by oxidising two molecules of reduced glutathione to the disulfide form. Its turnover is limited by how much reduced glutathione is available.

Cysteine availability sets the rate of glutathione synthesis, and NAC delivers cysteine in a stable form. More reduced glutathione means more cosubstrate for the peroxidase reaction.

Glutathione synthetase attaches glycine to gamma-glutamylcysteine to complete the tripeptide. Glycine supply becomes limiting for glutathione synthesis when demand is high.

Cysteine is the sulfur-bearing residue that carries the reducing thiol of glutathione and is the limiting input to its synthesis. The peroxidase reaction consumes that thiol on every turn.

Glutamate cysteine ligase joins glutamate to cysteine in the committed first step of glutathione synthesis. It is one of the three amino acids that make up the enzyme's cosubstrate.

Oxidised glutathione is returned to its reduced form by glutathione reductase, a flavoprotein that carries FAD derived from riboflavin. Poor riboflavin status slows the recycling that keeps the peroxidase supplied.

Riboflavin is the precursor of the FAD prosthetic group in glutathione reductase, the enzyme that regenerates reduced glutathione. The peroxidase cycle stalls when that recycling step lacks its cofactor.

Glutathione reductase draws its reducing equivalents from NADPH, which is built on the nicotinamide nucleotide pool. Adequate niacin status keeps that pool available for the recycling reaction.

Dihydrolipoic acid reduces oxidised glutathione back to its active thiol form, adding a second route alongside glutathione reductase. That keeps more cosubstrate available for the peroxidase.

Vitamin E interrupts the propagation of lipid radical chains in the membrane while glutathione peroxidase removes the lipid hydroperoxides those chains leave behind. The two halves of this defence are textbook partners.

Ascorbate regenerates tocopherol from its radical, which spares the glutathione pool that would otherwise be drawn on for the same job. Sparing glutathione leaves more cosubstrate for the peroxidase.

Catalase handles hydrogen peroxide at high concentration in peroxisomes while glutathione peroxidase handles it at low concentration in cytosol and mitochondria. The two cover different ranges of the same substrate.

Reduced coenzyme Q10 quenches lipid radicals inside the membrane and helps regenerate tocopherol, which lowers the hydroperoxide load reaching the peroxidase. The two act at different depths of the same lipid compartment.

Glutathione peroxidase spends two molecules of reduced glutathione for every peroxide it clears, and the oxidised glutathione is only recycled by glutathione reductase using NADPH. NADPH is built on the nicotinamide ring that comes from niacin. Without adequate NADP pools the recycling arm stalls even when selenium and glutathione are plentiful.

Cysteine, the rate-limiting amino acid for glutathione synthesis, is made from homocysteine and serine by cystathionine beta-synthase and cystathionine gamma-lyase, both of which require pyridoxal 5-phosphate. Low B6 status therefore constrains the substrate that glutathione peroxidase depends on. This is a cofactor relationship in the supply chain, not a direct effect on the enzyme itself.

Pyridoxal 5-phosphate is the coenzyme form used directly by the two transsulfuration enzymes that generate cysteine for glutathione synthesis. Supplying it as P5P skips the hepatic phosphorylation step that pyridoxine requires. The downstream logic for glutathione peroxidase is identical.

Methionine is the entry point of the transsulfuration pathway that produces cysteine, and cysteine availability sets the ceiling on glutathione synthesis. Glutathione is the reducing substrate glutathione peroxidase consumes. The connection is a well mapped precursor chain rather than a tested combination.

Betaine remethylates homocysteine back to methionine through betaine-homocysteine methyltransferase, which competes with the transsulfuration route that would have sent that homocysteine toward cysteine. The net effect on glutathione substrate supply therefore depends on overall methyl and sulfur balance rather than pushing in one direction. It is worth flagging precisely because the direction is not fixed.

S-adenosylmethionine is the allosteric activator of cystathionine beta-synthase, so it biases homocysteine toward the transsulfuration route that yields cysteine for glutathione. That is a documented regulatory step in hepatic sulfur handling. Whether supplemental SAM-e changes glutathione peroxidase activity in a person has not been established.

5-methyltetrahydrofolate donates the methyl group for the methionine synthase route back to methionine, so folate status shapes how much homocysteine is available to transsulfuration versus remethylation. That upstream split determines cysteine, and cysteine determines glutathione. The relationship to the enzyme is indirect and works through substrate supply.

Methionine synthase needs methylcobalamin to move a methyl group from folate to homocysteine. When B12 is low, homocysteine accumulates and one-carbon flux is disturbed in ways that alter sulfur amino acid handling. That places B12 upstream of the glutathione pool this enzyme consumes.

Whey carries a high proportion of cysteine and cystine relative to most dietary proteins, which is the mechanistic reason it is discussed as a glutathione substrate source. More reducing glutathione means more turnover capacity for glutathione peroxidase. Human measurements of glutathione peroxidase activity after whey are mixed and this should be read as a substrate argument.

Taurine is made from cysteine by cysteine dioxygenase and downstream decarboxylation, which is a route that draws on the same cysteine pool glutathione synthesis needs. Supplemental taurine spares that conversion, so it can free cysteine for glutathione, while high catabolic flux to taurine competes with it. Which way the balance falls in a given person has not been measured.

Glutathione peroxidases and the iodothyronine deiodinases are both selenoproteins competing for the same limited selenium supply, and when selenium is scarce the body prioritises some selenoproteins over others. Iodine and selenium status therefore interact at the level of selenoprotein synthesis. This is established trace element biochemistry and not a claim about thyroid function.

Superoxide dismutase generates the hydrogen peroxide that glutathione peroxidase then reduces, and the cytosolic isoform requires copper and zinc at its active site. The two enzymes sit in sequence, so copper status affects what arrives at glutathione peroxidase. Copper is also redox-active in free form, which is why status matters in both directions.

Zinc is the structural partner of copper in cytosolic superoxide dismutase and induces metallothionein, a cysteine-rich metal-binding protein that also scavenges reactive species. Both place zinc in the same handling network as glutathione peroxidase. High supplemental zinc restricts copper absorption, so the pair has to be considered together.

MnSOD converts mitochondrial superoxide to hydrogen peroxide, and glutathione peroxidase 1 and peroxiredoxin 3 clear that peroxide inside the same compartment. Manganese therefore sits directly upstream in the mitochondrial arm of this pathway. The relationship is enzymatic sequence, not a supplement combination result.

Free ferrous iron reacts with hydrogen peroxide to generate hydroxyl radical, so unbound iron competes with glutathione peroxidase for the same substrate and produces a far more damaging product. This is why iron is kept protein-bound in vivo. Practically it means iron status and peroxide-handling capacity have to be read together, not separately.

Melatonin appears repeatedly alongside glutathione peroxidase in the literature and is described both as a direct radical scavenger and as an inducer of antioxidant enzyme expression. Most of that work reports enzyme activity as a marker rather than a clinical outcome. The pairing is mechanistically coherent and the human outcome data is not established.

Quercetin is one of the flavonoids most often reported to shift Nrf2-driven expression of glutathione-related enzymes in cell and animal work. Its own oxidised form is regenerated by ascorbate and glutathione, which links it to the same reducing pool. Reported changes are in markers, not outcomes.

Pterostilbene is the dimethyl ether of resveratrol, which raises its membrane permeability and slows phase two conjugation. The same Nrf2-linked enzyme induction is reported for it in preclinical models. Human data on glutathione peroxidase activity with pterostilbene is not established.

Curcumin is a Michael acceptor that modifies cysteine residues on Keap1, which is the canonical route to inducing glutathione-related enzymes. It is one of the compounds most often co-reported with glutathione peroxidase measurements. Bioavailability is low without a formulation aid, and the reported endpoint is enzyme activity rather than a clinical result.

Sulforaphane is the reference Nrf2 activator: it reacts with Keap1 cysteines and increases transcription of glutathione synthesis and glutathione-conjugating enzymes. That places it upstream of the substrate supply for glutathione peroxidase. Reported human endpoints are enzyme and conjugate markers, not disease outcomes.

Broccoli sprout preparations deliver glucoraphanin, which needs plant myrosinase or gut bacterial thioglucosidase to become sulforaphane. Conversion efficiency varies widely between people and between products with and without active myrosinase. The downstream Nrf2 mechanism is the same one that supports glutathione enzyme expression.

Astaxanthin spans the lipid bilayer and quenches peroxyl radicals within the membrane, which is the compartment where glutathione peroxidase 4 acts on phospholipid hydroperoxides. The two work on the same class of lesion from different sides of the membrane. Human data reports marker changes rather than outcomes.

Catechins chelate transition metals and can both scavenge and, at high concentration, generate peroxide in cell culture. That dual behaviour puts them squarely in the pathway glutathione peroxidase handles. Reported effects on antioxidant enzyme activity are markers and the direction depends on dose.

Oligomeric proanthocyanidins are efficient hydrogen donors and are reported to interact with the ascorbate and glutathione recycling network. That places them alongside glutathione peroxidase in the same reducing chain. Evidence is largely in vitro and marker-based.

Pine bark proanthocyanidins behave like other condensed tannins as hydrogen donors and are described as participating in ascorbate and glutathione recycling. The relationship to glutathione peroxidase is through the shared reducing pool. Human reports are marker-level.

Silymarin is reported to raise hepatic glutathione content in animal models, which would supply the substrate glutathione peroxidase consumes in the tissue where it is most abundant. The mechanism is described as a mix of radical scavenging and altered synthesis. Human enzyme-activity data is not established.

Garlic organosulfur compounds such as S-allylcysteine carry a cysteine backbone and are reported to interact with cellular glutathione handling in preclinical work. That places them near the substrate pool for this enzyme. The evidence is preclinical and marker-based.

Beta-carotene quenches singlet oxygen and peroxyl radicals in lipid phases, complementing an enzyme that reduces lipid hydroperoxides once they have formed. At high oxygen tension carotenoids can themselves become pro-oxidant, so the interaction is conditional. Human evidence links carotenoid intake to marker changes, which is an association, not a cause.

Lycopene is among the most efficient singlet oxygen quenchers in the carotenoid family and partitions into membranes and lipoproteins. That is the same lipid compartment glutathione peroxidase 4 protects. The pairing rests on chemistry; human enzyme data is not established.

Creatine given alongside velocity-intentional variable resistance training was studied with antioxidant enzyme measures among the endpoints, which is why the pair is recorded rather than inferred. Any change in glutathione peroxidase activity there is a marker within an exercise context. It does not establish an independent effect of creatine on the enzyme.